In the last 12 months, insiders at Jade Biosciences, Inc. ($JBIO) filed 176 transactions with the SEC: 2 open-market purchases totaling $1,594,344 and 52 sales totaling $6,533,352. Net insider sentiment: net selling.
Jade Biosciences, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Fairmount Funds Management LLC (Director) — 2 transactions totaling $12,184,781
- Dake Benjamin T (SEE REMARKS) — 26 transactions totaling $1,997,505
- Eldridge George A (SEE REMARKS) — 28 transactions totaling $1,857,159
- RA CAPITAL MANAGEMENT, L.P. (Not found) — 3 transactions totaling $1,549,944
- Gillies Hunter (CHIEF MEDICAL OFFICER) — 37 transactions totaling $1,239,963
View all SEC Filings for Jade Biosciences, Inc. (JBIO).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | Balta Elizabeth | See Remarks | A | Common Stock | 28125 | $0.00 | 28,125.0000 | 46,004,205 | 9999.99% | 0.06% |
| Feb. 12, 2026 | Dahms Bradford D. | Chief Financial Officer | A | Stock Option (Right to Buy) | 226875 | $0.00 | 226,875.0000 | 46,004,205 | 9999.99% | 0.49% |
| Feb. 12, 2026 | Frohlich Tom | Chief Executive Officer | A | Common Stock | 78750 | $0.00 | 86,331.0000 | 46,004,205 | 1038.78% | 0.17% |
| Feb. 12, 2026 | Dahms Bradford D. | Chief Financial Officer | A | Common Stock | 37813 | $0.00 | 37,813.0000 | 46,004,205 | 9999.99% | 0.08% |
| Feb. 12, 2026 | Balta Elizabeth | See Remarks | A | Stock Option (Right to Buy) | 168750 | $0.00 | 168,750.0000 | 46,004,205 | 9999.99% | 0.37% |
| Feb. 12, 2026 | Frohlich Tom | Chief Executive Officer | A | Stock Option (Right to Buy) | 472500 | $0.00 | 472,500.0000 | 46,004,205 | 9999.99% | 1.03% |
| Feb. 12, 2026 | King Andrew James | See Remarks | A | Common Stock | 41250 | $0.00 | 386,113.0000 | 46,004,205 | 11.96% | 0.09% |
| Feb. 12, 2026 | King Andrew James | See Remarks | A | Stock Option (Right to Buy) | 247500 | $0.00 | 247,500.0000 | 46,004,205 | 9999.99% | 0.54% |
| Oct. 6, 2025 | Fairmount Funds Management LLC | Director | A | Common Stock | 1333126 | $9.14 | 4,553,494.0000 | 0 | 41.40% | 0.00% |
| Oct. 6, 2025 | Fairmount Funds Management LLC | Director | A | Pre-Funded Warrant (Right to Buy) | 855047 | $9.14 | 855,047.0000 | 0 | 9999.99% | 0.00% |
| July 14, 2025 | Dahms Bradford D. | Chief Financial Officer | A | Stock Option (Right to Buy) | 526000 | $0.00 | 526,000.0000 | 0 | 9999.99% | 0.00% |
| May 16, 2025 | Frohlich Tom | Chief Executive Officer | P | Common Stock | 6000 | $7.40 | 6,000.0000 | 0 | 9999.99% | 0.00% |
| April 29, 2025 | Fairmount Funds Management LLC | Not found | A | Stock Option (Right to Buy) | 23017 | $0.00 | 23,017.0000 | 0 | 9999.99% | 0.00% |
| April 29, 2025 | Lavelle Erin | Not found | A | Stock Option (Right to Buy) | 23017 | $0.00 | 23,017.0000 | 0 | 9999.99% | 0.00% |
| April 29, 2025 | DOBMEIER ERIC | Not found | A | Stock Option (Right to Buy) | 23017 | $0.00 | 23,017.0000 | 0 | 9999.99% | 0.00% |
| April 29, 2025 | CAIN CHRISTOPHER W. | Not found | A | Stock Option (Right to Buy) | 23017 | $0.00 | 23,017.0000 | 0 | 9999.99% | 0.00% |
| April 29, 2025 | Klein Lawrence Otto | Not found | A | Stock Option (Right to Buy) | 23017 | $0.00 | 23,017.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | J | Common Stock | 1062326 | $0.00 | 1,324,954.0000 | 0 | 404.50% | 0.00% |
| Aug. 1, 2024 | Dake Benjamin T | SEE REMARKS | M | Common Stock | 1507 | $1.74 | 14,252.0000 | 0 | 11.82% | 0.00% |
| July 31, 2024 | Dake Benjamin T | SEE REMARKS | M | Stock Option (Right to Buy) | 906 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 31, 2024 | Dake Benjamin T | SEE REMARKS | M | Stock Option (Right to Buy) | 10548 | $0.00 | 1,507.0000 | 0 | 87.50% | 0.00% |
| Aug. 1, 2024 | Dake Benjamin T | SEE REMARKS | M | Stock Option (Right to Buy) | 1507 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 31, 2024 | Dake Benjamin T | SEE REMARKS | M | Common Stock | 11454 | $1.74 | 12,745.0000 | 0 | 887.22% | 0.00% |
| June 17, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 928110 | $1.67 | 9,192,092.0000 | 0 | 11.23% | 0.00% |
| June 14, 2024 | Eldridge George A | SEE REMARKS | S | Common Stock | 15000 | $25.03 | 5,022.0000 | 0 | 74.92% | 0.00% |
| June 14, 2024 | Eldridge George A | SEE REMARKS | M | Stock Option (Right to Buy) | 15000 | $0.00 | 28,763.0000 | 0 | 34.28% | 0.00% |
| June 14, 2024 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | M | Common Stock | 10600 | $14.59 | 10,600.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | S | Common Stock | 10600 | $25.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 14, 2024 | Eldridge George A | SEE REMARKS | M | Common Stock | 15000 | $2.14 | 20,022.0000 | 0 | 298.69% | 0.00% |
| June 13, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 6000 | $2.14 | 11,602.0000 | 0 | 107.10% | 0.00% |
| June 13, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 6000 | $24.50 | 5,602.0000 | 0 | 51.72% | 0.00% |
| June 13, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 6000 | $0.00 | 83,510.0000 | 0 | 6.70% | 0.00% |
| June 14, 2024 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | M | Stock Option (Right to Buy) | 10600 | $0.00 | 68,800.0000 | 0 | 13.35% | 0.00% |
| June 5, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Santel Donald J | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Resnick Joshua | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Katabi Maha | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Iwicki Mark T | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | GRAYZEL DAVID S. | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Dable Habib J | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Dorval Allison | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 0 | 9999.99% | 0.00% |
| May 17, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 4000 | $2.14 | 9,602.0000 | 0 | 71.40% | 0.00% |
| May 16, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 1293 | $21.92 | 0.0000 | 0 | 100.00% | 0.00% |
| May 16, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 8707 | $21.52 | 1,293.0000 | 0 | 87.07% | 0.00% |
| May 16, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M | Common Stock | 10000 | $2.14 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| May 17, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 4000 | $0.00 | 11,324.0000 | 0 | 26.10% | 0.00% |
| May 17, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 86 | $21.86 | 5,602.0000 | 0 | 1.51% | 0.00% |
| May 17, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 3914 | $21.07 | 5,688.0000 | 0 | 40.76% | 0.00% |
| May 16, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 343,381.0000 | 0 | 2.83% | 0.00% |
| May 1, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 965 | $20.87 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 1357 | $19.91 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 353,381.0000 | 0 | 2.75% | 0.00% |
| May 1, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M | Common Stock | 10000 | $2.14 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| May 2, 2024 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | S | Common Stock | 1981 | $21.02 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 9035 | $20.34 | 965.0000 | 0 | 90.35% | 0.00% |
| April 17, 2024 | Dake Benjamin T | SEE REMARKS | S | Common Stock | 68 | $23.97 | 1,291.0000 | 0 | 5.00% | 0.00% |
| April 17, 2024 | Dake Benjamin T | SEE REMARKS | M | Common Stock | 6853 | $2.14 | 8,144.0000 | 0 | 530.83% | 0.00% |
| April 17, 2024 | Dake Benjamin T | SEE REMARKS | S | Common Stock | 6447 | $22.32 | 1,697.0000 | 0 | 79.16% | 0.00% |
| April 17, 2024 | Dake Benjamin T | SEE REMARKS | S | Common Stock | 338 | $23.17 | 1,359.0000 | 0 | 19.92% | 0.00% |
| April 17, 2024 | Dake Benjamin T | SEE REMARKS | M | Stock Option (Right to Buy) | 6853 | $0.00 | 95,936.0000 | 0 | 6.67% | 0.00% |
| April 17, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 4000 | $1.74 | 7,251.0000 | 0 | 123.04% | 0.00% |
| April 17, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 3689 | $22.30 | 3,562.0000 | 0 | 50.88% | 0.00% |
| April 17, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 311 | $23.33 | 3,251.0000 | 0 | 8.73% | 0.00% |
| April 17, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 503 | $0.00 | 2,511.0000 | 0 | 16.69% | 0.00% |
| April 17, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 3497 | $0.00 | 539.0000 | 0 | 86.65% | 0.00% |
| April 16, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 363,381.0000 | 0 | 2.68% | 0.00% |
| April 16, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M | Common Stock | 10000 | $2.14 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 4491 | $24.40 | 5,509.0000 | 0 | 44.91% | 0.00% |
| April 16, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 5509 | $24.94 | 0.0000 | 0 | 100.00% | 0.00% |
| April 10, 2024 | Eldridge George A | SEE REMARKS | S | Common Stock | 771 | $27.56 | 1,960.0000 | 0 | 28.23% | 0.00% |
| April 10, 2024 | Eldridge George A | SEE REMARKS | M | Common Stock | 7500 | $2.14 | 9,460.0000 | 0 | 382.65% | 0.00% |
| April 10, 2024 | Eldridge George A | SEE REMARKS | S | Common Stock | 6729 | $26.77 | 2,731.0000 | 0 | 71.13% | 0.00% |
| April 10, 2024 | Eldridge George A | SEE REMARKS | M | Stock Option (Right to Buy) | 7500 | $0.00 | 43,763.0000 | 0 | 14.63% | 0.00% |
| April 9, 2024 | GRAYZEL DAVID S. | Not found | S | Common Stock | 11882 | $28.15 | 1,799,232.0000 | 0 | 0.66% | 0.00% |
| April 1, 2024 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | S | Common Stock | 3796 | $28.87 | 1,504.0000 | 0 | 71.62% | 0.00% |
| April 1, 2024 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | S | Common Stock | 1504 | $30.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 1, 2024 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | M | Stock Option (Right to Buy) | 5300 | $0.00 | 79,400.0000 | 0 | 6.26% | 0.00% |
| April 1, 2024 | Eldridge George A | SEE REMARKS | M | Common Stock | 12495 | $2.14 | 14,455.0000 | 0 | 637.50% | 0.00% |
| April 1, 2024 | Eldridge George A | SEE REMARKS | S | Common Stock | 12495 | $31.23 | 1,960.0000 | 0 | 86.44% | 0.00% |
| April 1, 2024 | Eldridge George A | SEE REMARKS | M | Stock Option (Right to Buy) | 12495 | $0.00 | 15,768.0000 | 0 | 44.21% | 0.00% |
| April 1, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M | Common Stock | 10000 | $2.14 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 4502 | $28.96 | 5,498.0000 | 0 | 45.02% | 0.00% |
| April 1, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 1647 | $29.90 | 3,851.0000 | 0 | 29.96% | 0.00% |
| April 1, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 2851 | $31.02 | 1,000.0000 | 0 | 74.03% | 0.00% |
| April 1, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 1000 | $31.95 | 0.0000 | 0 | 100.00% | 0.00% |
| April 1, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 373,381.0000 | 0 | 2.61% | 0.00% |
| April 1, 2024 | Dake Benjamin T | SEE REMARKS | M | Common Stock | 3325 | $10.61 | 4,616.0000 | 0 | 257.55% | 0.00% |
| April 1, 2024 | Dake Benjamin T | SEE REMARKS | S | Common Stock | 3325 | $31.97 | 1,291.0000 | 0 | 72.03% | 0.00% |
| April 1, 2024 | Dake Benjamin T | SEE REMARKS | M | Stock Option (Right to Buy) | 3325 | $0.00 | 25,675.0000 | 0 | 11.47% | 0.00% |
| April 1, 2024 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | M | Common Stock | 5300 | $14.59 | 5,300.0000 | 0 | 9999.99% | 0.00% |
| March 28, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 9000 | $0.00 | 89,510.0000 | 0 | 9.14% | 0.00% |
| March 28, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 9000 | $29.50 | 3,251.0000 | 0 | 73.46% | 0.00% |
| March 28, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 9000 | $2.14 | 12,251.0000 | 0 | 276.84% | 0.00% |
| March 27, 2024 | Dake Benjamin T | SEE REMARKS | M | Stock Option (Right to Buy) | 11068 | $0.00 | 29,000.0000 | 0 | 27.62% | 0.00% |
| March 27, 2024 | Dake Benjamin T | SEE REMARKS | S | Common Stock | 11068 | $27.97 | 1,291.0000 | 0 | 89.55% | 0.00% |
| March 27, 2024 | Dake Benjamin T | SEE REMARKS | M | Common Stock | 11068 | $10.61 | 12,359.0000 | 0 | 857.32% | 0.00% |
| March 25, 2024 | Dake Benjamin T | SEE REMARKS | M | Stock Option (Right to Buy) | 3432 | $0.00 | 40,068.0000 | 0 | 7.89% | 0.00% |
| March 25, 2024 | Dake Benjamin T | SEE REMARKS | M | Common Stock | 3432 | $10.61 | 4,723.0000 | 0 | 265.84% | 0.00% |
| March 25, 2024 | Dake Benjamin T | SEE REMARKS | S | Common Stock | 3432 | $28.01 | 1,291.0000 | 0 | 72.67% | 0.00% |
| March 18, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 4000 | $1.74 | 7,251.0000 | 0 | 123.04% | 0.00% |
| March 18, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 3000 | $2.14 | 10,251.0000 | 0 | 41.37% | 0.00% |
| March 18, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 6387 | $25.81 | 3,864.0000 | 0 | 62.31% | 0.00% |
| March 18, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 613 | $26.40 | 3,251.0000 | 0 | 15.86% | 0.00% |
| March 18, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 4000 | $0.00 | 4,036.0000 | 0 | 49.78% | 0.00% |
| March 18, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 3000 | $0.00 | 98,510.0000 | 0 | 2.96% | 0.00% |
| March 18, 2024 | Dake Benjamin T | SEE REMARKS | M | Common Stock | 14500 | $10.61 | 36,348.0000 | 0 | 66.37% | 0.00% |
| March 18, 2024 | Dake Benjamin T | SEE REMARKS | S | Common Stock | 27476 | $25.74 | 8,872.0000 | 0 | 75.59% | 0.00% |
| March 18, 2024 | Dake Benjamin T | SEE REMARKS | S | Common Stock | 7581 | $26.48 | 1,291.0000 | 0 | 85.45% | 0.00% |
| March 18, 2024 | Dake Benjamin T | SEE REMARKS | M | Common Stock | 20557 | $2.14 | 21,848.0000 | 0 | 1592.33% | 0.00% |
| March 18, 2024 | Dake Benjamin T | SEE REMARKS | M | Stock Option (Right to Buy) | 20557 | $0.00 | 102,789.0000 | 0 | 16.67% | 0.00% |
| March 18, 2024 | Dake Benjamin T | SEE REMARKS | M | Stock Option (Right to Buy) | 14500 | $0.00 | 43,500.0000 | 0 | 25.00% | 0.00% |
| March 19, 2024 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | M | Common Stock | 5300 | $14.59 | 5,300.0000 | 0 | 9999.99% | 0.00% |
| March 19, 2024 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | S | Common Stock | 2536 | $25.68 | 2,764.0000 | 0 | 47.85% | 0.00% |
| March 19, 2024 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | S | Common Stock | 2764 | $26.46 | 0.0000 | 0 | 100.00% | 0.00% |
| March 19, 2024 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | M | Stock Option (Right to Buy) | 5300 | $0.00 | 84,700.0000 | 0 | 5.89% | 0.00% |
| March 13, 2024 | Eldridge George A | SEE REMARKS | S | Common Stock | 2016 | $25.02 | 1,960.0000 | 0 | 50.70% | 0.00% |
| March 12, 2024 | Eldridge George A | SEE REMARKS | M | Common Stock | 2051 | $2.14 | 4,011.0000 | 0 | 104.64% | 0.00% |
| March 12, 2024 | Eldridge George A | SEE REMARKS | S | Common Stock | 2051 | $25.05 | 1,960.0000 | 0 | 51.13% | 0.00% |
| March 13, 2024 | Eldridge George A | SEE REMARKS | M | Common Stock | 2016 | $2.14 | 3,976.0000 | 0 | 102.86% | 0.00% |
| March 12, 2024 | Eldridge George A | SEE REMARKS | M | Stock Option (Right to Buy) | 2051 | $0.00 | 53,279.0000 | 0 | 3.71% | 0.00% |
| March 13, 2024 | Eldridge George A | SEE REMARKS | M | Stock Option (Right to Buy) | 2016 | $0.00 | 51,263.0000 | 0 | 3.78% | 0.00% |
| March 11, 2024 | Eldridge George A | SEE REMARKS | S | Common Stock | 10 | $26.31 | 1,960.0000 | 0 | 0.51% | 0.00% |
| March 7, 2024 | Eldridge George A | SEE REMARKS | M | Stock Option (Right to Buy) | 20986 | $0.00 | 58,877.0000 | 0 | 26.28% | 0.00% |
| March 8, 2024 | Eldridge George A | SEE REMARKS | M | Stock Option (Right to Buy) | 114 | $0.00 | 58,763.0000 | 0 | 0.19% | 0.00% |
| March 7, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 945 | $0.00 | 15,324.0000 | 0 | 5.81% | 0.00% |
| March 7, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 8030 | $0.00 | 101,510.0000 | 0 | 7.33% | 0.00% |
| March 7, 2024 | Eldridge George A | SEE REMARKS | M | Stock Option (Right to Buy) | 1400 | $0.00 | 28,263.0000 | 0 | 4.72% | 0.00% |
| March 11, 2024 | Eldridge George A | SEE REMARKS | M | Stock Option (Right to Buy) | 3433 | $0.00 | 55,330.0000 | 0 | 5.84% | 0.00% |
| March 7, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 8975 | $2.14 | 12,226.0000 | 0 | 276.07% | 0.00% |
| March 7, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 8975 | $24.50 | 3,251.0000 | 0 | 73.41% | 0.00% |
| March 7, 2024 | Eldridge George A | SEE REMARKS | M | Common Stock | 22386 | $2.14 | 24,346.0000 | 0 | 1142.14% | 0.00% |
| March 7, 2024 | Eldridge George A | SEE REMARKS | S | Common Stock | 22386 | $25.00 | 1,960.0000 | 0 | 91.95% | 0.00% |
| March 8, 2024 | Eldridge George A | SEE REMARKS | M | Common Stock | 114 | $2.14 | 2,074.0000 | 0 | 5.82% | 0.00% |
| March 8, 2024 | Eldridge George A | SEE REMARKS | S | Common Stock | 114 | $25.00 | 1,960.0000 | 0 | 5.50% | 0.00% |
| March 11, 2024 | Eldridge George A | SEE REMARKS | M | Common Stock | 3433 | $2.14 | 5,393.0000 | 0 | 175.15% | 0.00% |
| March 11, 2024 | Eldridge George A | SEE REMARKS | S | Common Stock | 3423 | $25.24 | 1,970.0000 | 0 | 63.47% | 0.00% |
| March 4, 2024 | Dable Habib J | Not found | A | Stock Option (Right to Buy) | 1531 | $16.37 | 1,531.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 511 | $1.74 | 3,762.0000 | 0 | 15.72% | 0.00% |
| Feb. 23, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 511 | $19.50 | 3,251.0000 | 0 | 13.58% | 0.00% |
| Feb. 23, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 511 | $0.00 | 3,014.0000 | 0 | 14.50% | 0.00% |
| Feb. 20, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 898 | $20.58 | 3,251.0000 | 0 | 21.64% | 0.00% |
| Feb. 20, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 2502 | $0.00 | 3,525.0000 | 0 | 41.51% | 0.00% |
| Feb. 20, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 987 | $0.00 | 8,036.0000 | 0 | 10.94% | 0.00% |
| Feb. 20, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 3489 | $1.74 | 6,740.0000 | 0 | 107.32% | 0.00% |
| Feb. 20, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 2591 | $20.11 | 4,149.0000 | 0 | 38.44% | 0.00% |
| Feb. 5, 2024 | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 500 | $0.00 | 10,894.0000 | 0 | 4.39% | 0.00% |
| Feb. 5, 2024 | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 1200 | $0.00 | 34,908.0000 | 0 | 3.32% | 0.00% |
| Feb. 5, 2024 | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 1500 | $0.00 | 41,732.0000 | 0 | 3.47% | 0.00% |
| Feb. 5, 2024 | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 500 | $0.00 | 9,088.0000 | 0 | 5.21% | 0.00% |
| Feb. 5, 2024 | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 900 | $0.00 | 13,308.0000 | 0 | 6.33% | 0.00% |
| Feb. 5, 2024 | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 4600 | $17.45 | 1,609.0000 | 0 | 74.09% | 0.00% |
| Feb. 5, 2024 | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 3200 | $2.14 | 6,209.0000 | 0 | 106.35% | 0.00% |
| Feb. 5, 2024 | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 1400 | $1.74 | 3,009.0000 | 0 | 87.01% | 0.00% |
| Jan. 29, 2024 | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2024 | Dake Benjamin T | SEE REMARKS | A | Stock Options (Right to Buy) | 66586 | $0.00 | 66,586.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2024 | Eldridge George A | SEE REMARKS | A | Stock Options (Right to Buy) | 66586 | $0.00 | 66,586.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 66586 | $0.00 | 66,586.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2024 | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 66586 | $0.00 | 66,586.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2024 | Verwijs Marinus | CHIEF TECHNOLOGY OFFICER | A | Stock Option (Right to Buy) | 66586 | $0.00 | 66,586.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2024 | Pigot Timothy | CHIEF COMMERCIAL OFFICER | A | Stock Option (Right to Buy) | 66586 | $0.00 | 66,586.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 4000 | $0.00 | 6,027.0000 | 0 | 39.89% | 0.00% |
| Jan. 17, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | M | Common Stock | 4000 | $1.74 | 7,251.0000 | 0 | 123.04% | 0.00% |
| Jan. 17, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | S | Common Stock | 4000 | $19.50 | 3,251.0000 | 0 | 55.16% | 0.00% |
| Jan. 5, 2024 | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 1400 | $1.74 | 3,009.0000 | 0 | 87.01% | 0.00% |
| Jan. 5, 2024 | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 3200 | $2.14 | 6,209.0000 | 0 | 106.35% | 0.00% |
| Jan. 5, 2024 | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 2126 | $18.67 | 4,083.0000 | 0 | 34.24% | 0.00% |
| Jan. 5, 2024 | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 2474 | $19.57 | 1,609.0000 | 0 | 60.59% | 0.00% |
| Jan. 5, 2024 | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 900 | $0.00 | 14,208.0000 | 0 | 5.96% | 0.00% |
| Jan. 5, 2024 | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 500 | $0.00 | 9,588.0000 | 0 | 4.96% | 0.00% |
| Jan. 5, 2024 | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 500 | $0.00 | 11,394.0000 | 0 | 4.20% | 0.00% |
| Jan. 5, 2024 | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 1200 | $0.00 | 36,108.0000 | 0 | 3.22% | 0.00% |
| Jan. 5, 2024 | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 1500 | $0.00 | 43,232.0000 | 0 | 3.35% | 0.00% |
| Jan. 2, 2024 | GRAYZEL DAVID S. | Not found | A | Stock Option (Right to Buy) | 3186 | $13.49 | 3,186.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Katabi Maha | Not found | A | Stock Option (Right to Buy) | 3519 | $13.49 | 3,519.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Dable Habib J | Not found | A | Stock Option (Right to Buy) | 2964 | $13.49 | 2,964.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Santel Donald J | Not found | A | Stock Option (Right to Buy) | 2889 | $13.49 | 2,889.0000 | 0 | 9999.99% | 0.00% |